Pricing Log in Create free account
Saturday 17 October 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

STERIS plc (STE) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, STERIS plc (STE) trades at a price to free cash flow of 23.2×. Over the past ten years it has ranged from 13.8× (June 2015) to 61.8× (April 2022); the current reading is higher than 15% of that period. That is in line with the Medical Devices industry median of 23.7× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2026 22.1× (22.18%)
FY2025 28.4× (19.35%)
FY2024 35.2× (24.41%)
FY2023 46.6× (21.21%)
FY2022 59.1× 64.22%
FY2021 36.0× 15.31%
FY2020 31.2× 2.91%
FY2019 30.3× 15.32%
FY2018 26.3× 13.42%
FY2017 23.2× (40.40%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 22.0× (0.62%)
Mar 2026 22.1× (16.88%)
Dec 2025 26.6× 5.93%
Sep 2025 25.1× (2.55%)
42 more quarters

Against its own ten years

Low 13.8× High 61.8×
Ten-year median 31.9×
Current reading's percentile 15

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.4×
PHG Koninklijke Philips N.V. compare 13.3×
GMED Globus Medical, Inc. compare 14.1×
ZBH Zimmer Biomet Holdings, Inc. compare 17.6×
GEHC GE HealthCare Technologies Inc. compare 20.0×
STE STERIS plc 23.2×
DXCM DexCom, Inc. compare 23.4×
BIO.B Bio-Rad Laboratories, Inc. compare 27.4×
PEN Penumbra, Inc. compare 58.5×
Medical Devices industry median 23.7×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on STE